Chesnara Plc: Fourth acquisition in two years
12 November 2026
Investors with a keen eye on the biotechnology sector might find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect, especially given its considerable potential upside of 224.32%...
Autolus Therapeutics plc (NASDAQ: AUTL) is capturing the attention of investors with an impressive potential upside of 426.13%. This UK-based clinical-stage biopharmaceutical company is pioneering T..
For investors with an appetite for biotechnology stocks, uniQure N.V. (NASDAQ: QURE) presents an intriguing opportunity. With a market capitalization of $865.8 million, the Dutch-based company..
Celcuity Inc. (NASDAQ: CELC) stands at a fascinating juncture in the biotechnology sector, capturing significant investor attention with its innovative approach to cancer treatment. With a..
Akso Health Group (NASDAQ: AHG), a prominent player in China’s healthcare sector, has recently captured investor attention due to its remarkable revenue growth. With a staggering..
Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company focused on developing cancer therapies, is capturing investor attention with its promising pipeline and significant potential upside. Currently valued..
Oric Pharmaceuticals, Inc. (ORIC), a dynamic player in the biotechnology sector, is making waves with a robust pipeline aimed at tackling cancer resistance mechanisms. Headquartered in..
Regulus Therapeutics Inc. (NASDAQ: RGLS), a pioneering entity in the biotechnology sector, has captured the attention of investors with its innovative approach to treating genetically based..
ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is capturing investor attention with its remarkable potential upside of 112.44%, as indicated by the average analyst..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage biotech company based in Cambridge, Massachusetts, is making waves in the healthcare sector. With a market capitalization of $749.9..
With a promising pipeline in precision medicine, Tyra Biosciences, Inc. (NASDAQ: TYRA) has captured the attention of investors seeking exposure in the biotechnology sector. Despite a..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a pioneering biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to brain health medicines. Headquartered in..
In the ever-evolving landscape of biotechnology, Altimmune, Inc. (NASDAQ: ALT) is capturing investor attention with its robust potential upside of 367.39%. As a clinical-stage biopharmaceutical company,..
Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector specializing in diagnostics and research, offers investors a unique opportunity amidst a challenging financial landscape...
For investors keen on the dynamic biotechnology sector, Upstream Bio, Inc. (NASDAQ: UPB) presents an intriguing opportunity. With a focus on developing novel treatments for inflammatory..
Talkspace, Inc. (NASDAQ: TALK) is garnering significant attention in the healthcare sector, particularly within the health information services industry. Known for its innovative virtual behavioral healthcare..
Theravance Biopharma, Inc. (NASDAQ: TBPH) stands at the forefront of the biotechnology sector, making significant strides with its innovative therapeutic solutions for respiratory diseases. Based in..
For investors seeking opportunities in the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a compelling case, particularly given its significant potential upside. This medical device company,..
Auna SA (AUNA), a prominent healthcare service provider headquartered in Luxembourg, is drawing significant attention from investors due to its potential for substantial upside. Operating hospitals..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, is capturing the spotlight with its promising pipeline focused on childhood and adult..
